The objective of the consultation is to understand the current or potential availability of existing solutions in the market and to gather information to define the future procurement procedure, ensuring the participation of the maximum number of interested entities.

Specifically, the consultation is open to commercialized digital solutions for improving therapeutic adherence. This includes digital assistants and advanced analytics tools for estimation, risk characterization, and prediction of non-adherence. It also includes digital solutions that empower patients in managing their health and optimizing medication management, and finally, commercial solutions that can predict the risk of clinical events of interest related to medication optimization.

The purpose of the preliminary consultation is to identify available or potential AI solutions that improve adherence to pharmacological treatments, as well as to gather information to define the future procurement procedure.

Interested companies have until March 31 to fill out the questionnaire.

How to participate?

From Monday, March 17, until March 31, 2025 (inclusive), interested entities must fill out this online form

which will allow for assessing the availability of solutions to meet the presented needs, as well as their maturity and viability for adoption.

Companies that have responded to the questionnaire may request an optional virtual meeting of 30 minutes on April 2, 3, or 4 to present their proposal to the project team (AQuAS, Fundació TIC Salut Social, Consorci de Salut i Social de Catalunya, and Servei Català de la Salut). The questionnaire itself allows indicating the preferred time for the meeting.

All information is available on the Public Contracting Services Platform of the Generalitat de Catalunya.

For any questions, you can contact us at contractes.aquas@gencat.cat, indicating in the subject line “AI Challenge for Pharmacological Treatment Adherence”.